Skip to main
ISRG

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 37%
Buy 42%
Hold 16%
Sell 0%
Strong Sell 5%

Bulls say

Intuitive Surgical is the global leader in robotic-assisted minimally invasive surgery, developing, producing, and marketing the da Vinci surgical system. With over 10,000 systems installed worldwide, including a growing number in emerging markets, and a highly profitable business model, the company has a strong foundation for continued growth. Increased adoption of robotic surgery in the healthcare industry, improved system utilization, and expanding indications for the SP and Ion systems are all factors that contribute to a positive outlook for this stock.

Bears say

Intuitive Surgical is facing downward pricing pressure on refurbished systems and a slowdown in international placements, leading to a decline in ASPs. Despite the positive feedback on Force Feedback and FDA clearances for additional uses of the instrumentation, continued growth in this area is not enough to offset other growth headwinds. While the potential for robotic surgery is promising, competition and margin compression in the near term hinder long-term profitability.

Intuitive Surgical (ISRG) has been analyzed by 19 analysts, with a consensus rating of Buy. 37% of analysts recommend a Strong Buy, 42% recommend Buy, 16% suggest Holding, 0% advise Selling, and 5% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 19 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of May 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $591.84, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $591.84, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.